PL386174A1 - Sposób wiązania lipopolisacharydów bakteryjnych do fazy stałej - Google Patents

Sposób wiązania lipopolisacharydów bakteryjnych do fazy stałej

Info

Publication number
PL386174A1
PL386174A1 PL386174A PL38617408A PL386174A1 PL 386174 A1 PL386174 A1 PL 386174A1 PL 386174 A PL386174 A PL 386174A PL 38617408 A PL38617408 A PL 38617408A PL 386174 A1 PL386174 A1 PL 386174A1
Authority
PL
Poland
Prior art keywords
solid phase
bonding
lipopolysaccharides
purification
subject
Prior art date
Application number
PL386174A
Other languages
English (en)
Other versions
PL217758B1 (pl
Inventor
Tomasz Lipiński
Jacek Rybka
Andrzej Gamian
Original Assignee
Instytut Immunologii i Terapii Doświadczalnej PAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Immunologii i Terapii Doświadczalnej PAN filed Critical Instytut Immunologii i Terapii Doświadczalnej PAN
Priority to PL386174A priority Critical patent/PL217758B1/pl
Priority to PCT/PL2009/050026 priority patent/WO2010036133A1/en
Priority to US13/059,539 priority patent/US8426221B2/en
Priority to EP09752002.7A priority patent/EP2328927B1/en
Priority to ES09752002.7T priority patent/ES2560779T3/es
Publication of PL386174A1 publication Critical patent/PL386174A1/pl
Publication of PL217758B1 publication Critical patent/PL217758B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Sustainable Development (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Przedmiotem wynalazku jest sposób otrzymywania złóż do chromatografii powinowactwa ze związanymi w niekowalencyjny i trwały sposób cząsteczkami lipopolisacharydu bakteryjnego. Uzyskane według wynalazku złoże może być wykorzystane w chromatografii powinowactwa do oczyszczania przeciwciał przeciwko lipopolisacharydom. Szczególnie przydatne jest do oczyszczania przeciwciał skierowanych przeciwko labilnym epitopom lipopolisacharydów, które ulegały degradacji w dotąd używanych warunkach kowalencyjnego wiązania cząsteczek lipopolisacharydu do fazy stałej.
PL386174A 2008-09-29 2008-09-29 Sposób otrzymywania złoża do chromatografii powinowactwa i zastosowanie otrzymanego tym sposobem złoża PL217758B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL386174A PL217758B1 (pl) 2008-09-29 2008-09-29 Sposób otrzymywania złoża do chromatografii powinowactwa i zastosowanie otrzymanego tym sposobem złoża
PCT/PL2009/050026 WO2010036133A1 (en) 2008-09-29 2009-09-27 A method of binding bacterial lipopolysaccharides to a solid phase
US13/059,539 US8426221B2 (en) 2008-09-29 2009-09-27 Method of binding bacterial lipopolysaccharides to a solid phase
EP09752002.7A EP2328927B1 (en) 2008-09-29 2009-09-27 A method of binding bacterial lipopolysaccharides to a solid phase
ES09752002.7T ES2560779T3 (es) 2008-09-29 2009-09-27 Un procedimiento de unión de lipopolisacáridos bacterianos a una fase sólida

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL386174A PL217758B1 (pl) 2008-09-29 2008-09-29 Sposób otrzymywania złoża do chromatografii powinowactwa i zastosowanie otrzymanego tym sposobem złoża

Publications (2)

Publication Number Publication Date
PL386174A1 true PL386174A1 (pl) 2010-04-12
PL217758B1 PL217758B1 (pl) 2014-08-29

Family

ID=41531725

Family Applications (1)

Application Number Title Priority Date Filing Date
PL386174A PL217758B1 (pl) 2008-09-29 2008-09-29 Sposób otrzymywania złoża do chromatografii powinowactwa i zastosowanie otrzymanego tym sposobem złoża

Country Status (5)

Country Link
US (1) US8426221B2 (pl)
EP (1) EP2328927B1 (pl)
ES (1) ES2560779T3 (pl)
PL (1) PL217758B1 (pl)
WO (1) WO2010036133A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
WO2017042303A1 (en) * 2015-09-08 2017-03-16 Danmarks Tekniske Universitet Binding of hydrophobic antigens to surfaces
WO2023007456A1 (en) * 2021-07-30 2023-02-02 Biovetika Spółka Z Ograniczoną Odpowiedzialnością A method for producing complexes of proteins with bacterial lipopolysaccharides, the use thereof, a vaccine comprising an lps/protein immunogenic complex and a method for producing the vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660197B1 (fr) 1990-04-03 1994-10-21 Fondation Nale Transfusion San Anticorps purifies specifiquement diriges contre les lipopolysaccharides (lps) des bacteries gram negatif.
JP2002532719A (ja) * 1998-12-15 2002-10-02 エクシコン エ/エス リポ多糖類由来糖質の固相表面へのカップリング

Also Published As

Publication number Publication date
EP2328927A1 (en) 2011-06-08
PL217758B1 (pl) 2014-08-29
US8426221B2 (en) 2013-04-23
EP2328927B1 (en) 2015-12-23
US20110230648A1 (en) 2011-09-22
ES2560779T8 (es) 2016-03-08
ES2560779T3 (es) 2016-02-22
WO2010036133A1 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
MA32754B1 (fr) Molécule de liaison à l'antigène capable de se lier à deux molécules d'antigène ou plus de manière répétée
DK2681244T3 (da) Cea-antistoffer
EA201790757A1 (ru) Связывающие антиген cd27l белки
EA201000717A1 (ru) Молекулы и способы, предназначенные для модуляции компонента системы комплемента
DK2185574T3 (da) Antistoffer og relaterede molekyler, der bindes til 24P4C12-proteiner
EP4324850A3 (en) Therapeutic antigen-binding molecule with a fcrn-binding domain that promotes antigen clearance
CR11319A (es) Proteinas de union a antigeno capaces de unirse a linfopoyetina estromatica timica
EA201000979A1 (ru) Улучшенные связывающие молекулы на основе фибронектина и их применение
EA201490768A1 (ru) Применение молекул, связывающих семафорин-4d, для модуляции проницаемости гематоэнцефалического барьера
ZA200907385B (en) Binding proteins, including antibodies, antibody derivative and antibody fragments, that specifically bind cd154 and uses thereof
DK2135881T3 (da) Antistoffer, som binder til det tumor-associerede antigen TAT10772, til diagnose og behandling af tumor
WO2008120202A3 (en) Antibodies, methods and kits for diagnosing and treating melanoma
NZ601615A (en) Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
WO2008003103A3 (en) Novel multivalent immunoglobulins
MX2011011754A (es) Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c3b.
UY31904A (es) Anticuerpos contra il-6 y sus usos
EA200900492A1 (ru) Молекулы антител, которые связываются с il-17a и il-17f
ZA200901590B (en) Antigen binding molecules that bind egfr,vectors encoding same,and uses thereof
DK1742966T3 (da) Antistoffer og molekyler afledt deraf som binder til STEAP-1 proteiner
ES2639026T3 (es) Anticuerpos totalmente humanos específicos para CADM1
MX2009008608A (es) Anticuerpos monoclonales anti-cxcl13.
WO2009130459A3 (en) Epitopes of il-17a and il-17f and antibodies specific thereto
MX2010001237A (es) Nuevos anticuerpos.
PL386174A1 (pl) Sposób wiązania lipopolisacharydów bakteryjnych do fazy stałej
WO2012099949A3 (en) Antibody purification via affinity chromatography